Research Topics | Memorial Sloan Kettering Cancer Center

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Sloan Kettering Institute
Research
- - Changing how the world understands and treats cancer
    Our scientists pursue every aspect of cancer research—from exploring the biology of genes and cells, to developing immune-based treatments, uncovering the causes of metastasis, and more.
- - Programs & Centers
  - Sloan Kettering Institute
    Pursuing basic and translational research across 9 programs and 100+ labs
  - Memorial Hospital research
    Focusing on clinical cancer research and population health
  - Human Oncology & Pathogenesis Program (HOPP)
    Bridging the lab and the clinic through translational research
  - Collaborative research centers
    Fostering interdisciplinary collaborations between laboratory scientists and clinicians
  - Extramural collaborations
    Partnering with other academic and research institutions
- - Research at MSK
  - Our research impact
  - Research topics
  - Core facilities & resources
    Offering state-of-the-art resources for our researchers
  - Find a researcher or lab
  - Education & training programs
  - MSK Innovation
  - MSK Commercialization Ecosystem
    Partnering, new ventures, and business accelerators
  - Clinical Trial Innovation
    Incubating and implementing better ways to run clinical trials
  - Our Innovation Story
    Showcasing key developments and achievements
Education & Training
- - Training the next generation of clinicians and scientists
    Our highly-specialized educational programs shape leaders to be at the forefront of cancer care and research.
Careers
MSK Direct
Locations & Language
In the U.S.
Outside of the U.S.

Make an Appointment
Back
Make an Appointment
- - We're here for you.
    Make an appointment
    New patient
    Current patient
    Speak to a care advisor
    Adults: 800-525-2225
    Available 24 hours a day, 7 days a week
    Children & Teens: 833-MSK-KIDS
    Monday through Friday, 9 a.m. to 5:30 p.m. (Eastern time)
Learn About Cancer & Treatment
Back
Learn About Cancer & Treatment
- - We treat every type of cancer, including the most important one: yours.
    With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need, when you need it.
- - Adults
  - Cancers & conditions
  - Risk assessment & screening
  - Diagnosis & treatment
  - Clinical trials
  - Children & Teens
  - Cancers & conditions
  - Diagnosis & treatment
  - Clinical trials
- - Support, Services & Programs
  - For adults
  - For children & teens
  - For caregivers
  - Adolescents & young adult (AYA) program
  - Patient & caregiver education library
  - Cancer News & Discoveries
  - Read the latest
  - Sign up for our newsletter
For Physicians
Back
For Physicians
- - Partner with us to treat your patient’s cancer.
    Refer a patient
    CALL OUR DEDICATED CLINICIAN ACCESS NUMBER
    646-677-7440
    Monday through Friday, 8 a.m. to 6 p.m. (Eastern time)
- - Clinical Resources
  - Our doctors
  - Physician relations
  - Clinical updates & insights
  - Prediction tools
  - Clinical trials
  - Continuing medical education (CME)
About Us
Back
About Us
- - Our mission: Ending cancer for life.
    Memorial Sloan Kettering was founded in 1884, and today is a world leader in patient care, research, and educational programs.
- - About Us
  - Our mission, vision & core values
  - Leadership
  - History
  - Equality, diversity & inclusion
  - Annual report
  - Give to MSK
  - For the Media
  - Media inquiries
  - Press Releases
  - Newsroom
- - Have Questions?
  - Contact us
  - Plan Your Visit
  - Explore our locations
  - Directions
  - Visitor policy
MSK MyChart
Donate Now
- Sloan Kettering Institute
- Research
  Back
  Research
  - Programs & Centers
    Sloan Kettering Institute
    Pursuing basic and translational research across 9 programs and 100+ labs
    Memorial Hospital research
    Focusing on clinical cancer research and population health
    Human Oncology & Pathogenesis Program (HOPP)
    Bridging the lab and the clinic through translational research
    Collaborative research centers
    Fostering interdisciplinary collaborations between laboratory scientists and clinicians
    Extramural collaborations
    Partnering with other academic and research institutions
  - Research at MSK
    Our research impact
    Research topics
    Core facilities & resources
    Offering state-of-the-art resources for our researchers
    Find a researcher or lab
    Education & training programs
    MSK Innovation
    MSK Commercialization Ecosystem
    Partnering, new ventures, and business accelerators
    Clinical Trial Innovation
    Incubating and implementing better ways to run clinical trials
    Our Innovation Story
    Showcasing key developments and achievements
- Education & Training
  Back
  Education & Training
  - For Healthcare
    Graduate medical education (GME)
    Medical student opportunities
    Continuing medical education (CME)
    Continuing nursing education (CNE)
    Academic departments & divisions
    Explore all programs
  - For Research
    Postdoctoral training
    Gerstner Sloan Kettering Graduate School of Biomedical Sciences
    PhD & MD/PhD programs
    Explore all programs
- Careers
- MSK Direct
- Locations & Language
  Back
  Locations & Language
  In the U.S.
  English
  Español
  Pусский
  Outside of the U.S.
  العَرَبِيَّة
  Deutsch
  English
  Español
  한국어
  עִבְרִית
  Italiano
  Portugês
  Pу́сский
  Türkçe
  中文

At Memorial Sloan Kettering, scientific inquiry unites researchers with diverse expertise from across our academic programs and medical departments. Learn about some of our most intensively pursued topics of investigation.

using the genetics and genomics of cancer to create new treatment options

Cancer Genetics & Genomics

Pictured: Immune system cells called T cells (orange) have detected a cancer cell and attached to it. Innovative drugs pioneered by Memorial Sloan Kettering researchers stimulate the ability of T cells to recognize and destroy cancer cells.

Cancer Immunotherapy & Vaccines

Pictured: A cell structure called mitochondrion imaged by transmission electron microscopy. Within mitochondria, sugars and fats are oxidized to produce energy needed for diverse cell functions.

Cancer Metabolism

Pictured: Two mesothelioma cells connected by long extensions called tunneling nanotubes, which potentially may be a conduit for communication between the cells.

Cell Signaling & Regulation

Pictured: Immature nerve cells generated from induced pluripotent stem cells by cell engineering. Memorial Sloan Kettering researchers are at the forefront of developing cell-based therapies for cancer and other diseases, including central nervous system disorders.

Cell-Based Therapy

Pictured: Chemical biologist investigating the use of chemical tools to study and manipulate biological systems.

Chemical Biology

Computational oncology experts

Computational Oncology

Pictured: An early structure of a developing mouse embryo called a blastocyst, imaged by confocal 3-D microscopy. The colored areas represent cell layers called the epiblast (pink) and the primitive endoderm (blue).

Developmental Biology

Pictured: Biostatisticians Venkatraman Seshan (left) and Ronglai Shen use computational methods to analyze cancer genome data.

Epidemiology, Statistics & Health Outcomes

Memorial Sloan Kettering scientists in the area of epigenetics

Pictured: Exercise physiologist supervisor Meghan Michalski with a patient

Exercise, Nutrition, and Cancer

Pictured: An X and a Y chromosome from a cell undergoing meiosis, an event that leads to the formation of sperm or egg cells, imaged by electron microscopy. One end of each chromosome is joined at the site where DNA is exchanged between the chromosomes by homologous recombination. Cells also use this process to repair some types of DNA damage.

Genome Integrity

Pictured: Richard O’Reilly, Chief of the Pediatric Bone Marrow Transplant Service, with a patient. Dr. O’Reilly is studying the immunology of stem-cell transplants and developing new cell-based therapies for children with blood disorders.

Hematologic Malignancies

Pictured: A cross section of a piece of breast tumor tissue imaged by confocal mosaicking microscopy, a method Memorial Sloan Kettering researchers are developing to make pathology in the OR more effective.

Pictured: Developing white blood cells called T cells on the surface of the thymus. T cells defend the body from foreign intruders such as bacteria, viruses, and fungi, and may also protect against cancer.

Pictured: A zebrafish with melanoma that has spread throughout the body. The tumors have been engineered to light up in green, providing a powerful model for research into the biology of metastasis.

Metastasis & Drug Resistance

Pictured: Clostridium difficile, a bacterium that often infects cancer patients, imaged by scanning electron microscopy.

Microbiome & Inflammation

Molecular Pathology & Diagnostics

Pictured: Close-up view of the structure of a carbon nanotube, a cylindrical particle formed by carbon atoms linked in a hexagonal shape. Our scientists are exploring the use of carbon nanotubes for imaging, drug delivery, and other applications.

Pictured: Immature nerve cells are differentiating into the pain-sensing cells of the peripheral nervous system.

Neuroscience & Neuro-Oncology

Pictured: A metastatic breast cancer cell (green) has infiltrated the brain and is holding on tightly to a blood capillary (purple).

Solid Tumor Oncogenesis

Pictured: Nerve cells generated from embryonic stem cells and manipulated by a technology called optogenetics. Memorial Sloan Kettering scientists are using stem-cell engineering to develop new treatments for Parkinson’s disease.

Pictured: Two mesothelioma cells connected by long extensions called tunneling nanotubes, which potentially may be a conduit for communication between the cells.

Structural Biology

Pictured: Pseudomonas aeruginosa, a common bacterium, growing in a petri dish. Colonies on the right migrate more quickly than those on the left due to a complex group behavior called swarming.

Systems Biology

Physician-scientist and soft tissue sarcoma expert Ping Chi

Targeted Therapy

tumor in microenvironment

Tumor Microenvironment